MYRIAD GENETICS INC (MYGN) Stock Analyst Ratings
NASDAQ:MYGN - Nasdaq - US62855J1043 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 55% to MYGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.65. This target is 55.49% above the current price.
MYGN was analyzed by 22 analysts. The buy percentage consensus is at 55. So analysts seem to be rather neutral about MYGN.
In the last month the buy percentage fell by 14 points. So the trust of analysts is decreasing.
MYGN was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-21 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-05-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-08 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-05-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-07 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-05-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-09 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-04-01 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-03-12 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-03-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-03 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-02-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-25 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-02-12 | Craig-Hallum | Initiate | Buy |
| 2025-01-30 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-16 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-12-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-12-10 | UBS | Initiate | Neutral |
| 2024-12-09 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-11-18 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-09-19 | Morgan Stanley | Initiate | Equal-Weight |
| 2024-08-27 | Wells Fargo | Initiate | Overweight |
| 2024-08-13 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-08-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-08-07 | TD Cowen | Maintains | Hold -> Hold |
| 2024-08-07 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-06-27 | ScotiaBank | Initiate | Sector Outperform |